Injectable Drug Delivery Market
Global Injectable Drug Delivery Market Size, Share & Trends Analysis Report by Mode of Administration (Oral and Pulmonary), by Usability (Reusable and Disposable), and by End-User (Hospitals & Clinics, Home Care Settings, and Other) Forecast Period (2022-2028) Update Available - Forecast 2024-2030
The global injectable drug delivery market is anticipated to grow at a significant CAGR of 12.8% during the forecast period. The major factor driving the growth of the global injectable drug delivery market is the rising prevalence and incidence of chronic diseases such as diabetes, hormonal disorder, reproductive health issue, and other major diseases. According to the Centers for Disease Control and Prevention (CDC), around 129 million (51.8%) non-institutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. Additionally, 24.6% (61 million) of adults had 1 chronic condition, and 27.2% (68 million) had equal or more than 2 chronic conditions. Furthermore, as per American Action Forum, the total cost of chronic disease in the US reaches $3.7 trillion each year which is almost 19.6% of the country’s gross domestic product (GDP). Additionally, the rising demand for generic injectables and biosimilar as well as rapid technological advancements in the field of injectable drug delivery will offer lucrative growth opportunities for the market during the forecast period.
Impact of COVID-19 Pandemic on Global Injectable Drug Delivery Market
During COVID-19, as of May 2020, 212 countries had been impacted by the pandemic, and the governments of these countries had ordered nationwide lockdowns which shut down operations of various industries. Additionally, the global injectable drug delivery market was also impacted by the COVID-19 pandemic due to the operational and logistic challenges faced by the market players due to lockdowns. However, the surge in the rising number of patients due to COVID-19 infection tremendously increased the demand for injectable drug delivery which presented lucrative growth opportunities for the growth of the market during the COVID-19 pandemic.
Segmental Outlook
The global injectable drug delivery market is segmented based on the mode of administration, usability, and end-user. Based on the mode of administration, the market is sub-segmented into oral and pulmonary. Based on usability, the market is sub-segmented into reusable and disposable. Based on the end-user, the market is sub-segmented into hospitals & clinics, home care settings, and others.
Global Injectable Drug Delivery Market Share by End-User, 2021 (%)
Hospitals & Clinics Segment to Hold a Prominent Share in the Global Injectable Drug Delivery Market
Based on the end-user, the hospitals & clinics segment in the global injectable drug delivery market is expected to hold a prominent share in 2021. The factor driving the hospitals & clinics segment is the rising prevalence of chronic diseases that requires hospitalization as well as the rising number of patients due to infectious diseases along with technological advancements.
Regional Outlook
The global injectable drug delivery market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Germany, Italy, Spain, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The Asia-Pacific region is anticipated to grow during the forecast period due to the improving healthcare system in the region.
Global Injectable Drug Delivery Market Growth by Region, 2022-2028
North America Region Holds a Prominent Share in the Global Injectable Drug Delivery Market
The North American region holds a prominent share in the injectable drug delivery market. The major factor driving the growth of the market in the region is the robust healthcare infrastructure as well as the increasing geriatric population in the region. According to the ACL Administration for Community Living, there were 54.1 million people age 65 and older in the US which represented 16% of the population, more than one in every seven Americans.
Market Players Outlook
The major companies serving the global injectable drug delivery market include Becton, Dickinson and Co., Baxter International Inc., Eli Lilly and Co., GlaxoSmithKline PLC, and Pfizer Inc., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, and geographical expansion, to stay competitive in the market. For instance, in July 2019, Neuro Pharma GmbH announced to D-MINE pump for patients with Parkinson’s disease. The device delivers constant subcutaneous drug delivery and is appropriate for use of the patient.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global injectable drug delivery market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1.Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Injectable Drug Delivery Market
- Recovery Scenario of Global Injectable Drug Delivery Market
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.By Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.Key Company Analysis
3.1.1.Becton, Dickinson, and Co.
3.1.1.1.Overview
3.1.1.2.Financial Analysis
3.1.1.3.SWOT Analysis
3.1.1.4.Recent Developments
3.1.2.Baxter International Inc.
3.1.2.1.Overview
3.1.2.2.Financial Analysis
3.1.2.3.SWOT Analysis
3.1.2.4.Recent Developments
3.1.3.Eli Lilly and Co.
3.1.3.1.Overview
3.1.3.2.Financial Analysis
3.1.3.3.SWOT Analysis
3.1.3.4.Recent Developments
3.1.4.GlaxoSmithKline PLC
3.1.4.1.Overview
3.1.4.2.Financial Analysis
3.1.4.3.SWOT Analysis
3.1.4.4.Recent Developments
3.1.5.Pfizer Inc.
3.1.5.1.Overview
3.1.5.2.Financial Analysis
3.1.5.3.SWOT Analysis
3.1.5.4.Recent Developments
3.2.Key Strategy Analysis
3.3.Impact of COVID-19 on Key Players
4.Market Segmentation
4.1.Global Injectable Drug Delivery Market by Mode of Administration
4.1.1.Oral
4.1.2.Pulmonary
4.2.Global Injectable Drug Delivery Market by Usability
4.2.1.Reusable
4.2.2.Disposable
4.3.Global Injectable Drug Delivery Market by End-User
4.3.1.Hospitals & Clinics
4.3.2.Home Care Settings
4.3.3.Others
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Alkermes PLC
6.2.Antares Pharma
6.3.Genentech Inc.
6.4.Gerresheimer AG
6.5.Hikma Pharmaceuticals PLC
6.6.Lifelong Meditech Ltd.
6.7.Novartis AG
6.8.Schott AG
6.9.SHL Group
6.10.Terumo Corp.
6.11.Teva Pharmaceutical Industries Ltd.
6.12.Troikaa Pharmaceuticals Ltd.
1.GLOBAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY MODE OF ADMINISTRATION, 2021-2028 ($ MILLION)
2.GLOBAL ORAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL PULMONARY INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY USABILITY, 2021-2028 ($ MILLION)
5.GLOBAL REUSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL DISPOSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7.GLOBAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
8.GLOBAL INJECTABLE DRUG DELIVERY FOR HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9.GLOBAL INJECTABLE DRUG DELIVERY FOR HOME CARE SETTINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10.GLOBAL INJECTABLE DRUG DELIVERY FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
12.NORTH AMERICAN INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13.NORTH AMERICAN INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY MODE OF ADMINISTRATION, 2021-2028 ($ MILLION)
14.NORTH AMERICAN INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY USABILITY, 2021-2028 ($ MILLION)
15.NORTH AMERICAN INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
16.EUROPEAN INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17.EUROPEAN INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY MODE OF ADMINISTRATION, 2021-2028 ($ MILLION)
18.EUROPEAN INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY USABILITY, 2021-2028 ($ MILLION)
19.EUROPEAN INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
20.ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21.ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY MODE OF ADMINISTRATION, 2021-2028 ($ MILLION)
22.ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY USABILITY, 2021-2028 ($ MILLION)
23.ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
24.REST OF THE WORLD INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
25.REST OF THE WORLD INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY MODE OF ADMINISTRATION, 2021-2028 ($ MILLION)
26.REST OF THE WORLD INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY USABILITY, 2021-2028 ($ MILLION)
27.REST OF THE WORLD INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL INJECTABLE DRUG DELIVERY MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL INJECTABLE DRUG DELIVERY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL INJECTABLE DRUG DELIVERY MARKET, 2022-2028 (%)
4.GLOBAL INJECTABLE DRUG DELIVERY MARKET SHARE BY MODE OF ADMINISTRATION, 2021 VS 2028 (%)
5.GLOBAL ORAL INJECTABLE DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL PULMONARY INJECTABLE DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL INJECTABLE DRUG DELIVERY MARKET SHARE BY USABILITY, 2021 VS 2028 (%)
8.GLOBAL REUSABLE INJECTABLE DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL DISPOSABLE INJECTABLE DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10.GLOBAL INJECTABLE DRUG DELIVERY MARKET SHARE BY END-USER, 2021 VS 2028 (%)
11.GLOBAL INJECTABLE DRUG DELIVERY FOR HOSPITALS & CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12.GLOBAL INJECTABLE DRUG DELIVERY FOR HOME CARE SETTINGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13.GLOBAL INJECTABLE DRUG DELIVERY FOR OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL INJECTABLE DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15.US INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
16.CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
17.UK INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
18.FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
19.GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
20.ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
21.SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
22.REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
23.INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
24.CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
25.JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
26.SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
27.REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
REST OF THE WORLD INJECTABLE DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
